-
SouthernCare Inc. and its shareholders agreed to pay the United States a total of $24.7 million to settle allegations that the company submitted false claims to the government for patients treated at its hospice facilities, the U.S. Justice Department reported in mid-January.
-
Q & A with Felicia Cohn, PhD, director of medical ethics, University of California, Irvine, School of Medicine.
-
If you ask Laura Ann Wagner, president and CEO of In-House Hopice, based in Southfield, MI, the explanation why costs are increasing for the Medicare hospice benefit the answer is a simple one: Baby boomers are aging, and more of them are taking advantage of that benefit.
-
[Editor's note: Medical Ethics Advisor will update this story in the April issue. Prior to press time, NHPCO secured a one-year moratorium on cuts in the Medicare Hospice Benefit via President Barack Obama's signing of The American Recovery and Reinvestment Act of 2009.]
-
Planned Parenthood Federation of America (PPFA) and Planned Parenthood of Connecticut were among those filing lawsuits asking the U.S. District Court for the District of Connecticut to invalidate the administrative regulation finalized in December by the U.S. Department of Health aÿ
-
President Obama may have signed the $787 billion stimulus package with the expectation that it will create jobs and jumpstart the economy, but businesses including those in the business of health care are still feeling financial pain.
-
Sen. Chuck Grassley (R-Iowa) and Sen. Herb Kohl (D-WI) have introduced legislation that would require not only pharmaceutical companies, but also makers of medical devices and biologics, to publicly report any money over $100 that they give to physicians within a year.
-
In trying to replicate the Milgram obedience experiments, social psychologist Jerry Burger had to balance the goal of getting useful results that were roughly comparable with Milgram's, while providing more protection for participants from severe stress.
-
In planning the recently launched National Children's Study (NCS), researchers knew that ethical and IRB issues would be front and center.
-
IRBs that deal with social-behavioral-educational research might need to give investigators who also conduct biomedical research updated information and education about how to handle informed consent.